Levodopa Prescription Patterns in Patients with Advanced Parkinson’s Disease: A Japanese Database Analysis

Off Time Independently Affects Quality of Life in Advanced Parkinson’s Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson’s Disease (JAQPAD) Study

(2021) Yuka Hayashi et al.   Parkinsons Disease

Parkinson’s disease: etiopathogenesis and treatment

(2020) Joseph Jankovic et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study

(2020) Nobutaka Hattori et al.   PARKINSONISM & RELATED DISORDERS

History and Profile of Diagnosis Procedure Combination (DPC): Development of a Real Data Collection System for Acute Inpatient Care in Japan

(2020) Kenshi Hayashida et al.   JOURNAL OF EPIDEMIOLOGY

Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study

(2020) Kanako Kurihara et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Dysphagia predicts poor outcome in late-stage Parkinson's disease

(2019) Margherita Fabbri et al.   PARKINSONISM & RELATED DISORDERS

Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients

(2019) Alfonso Fasano et al.   BMC Neurology

Real-world pharmacological treatment patterns of patients with young-onset Parkinson’s disease in Japan: a medical claims database analysis

(2019) Sachiko Kasamo et al.   JOURNAL OF NEUROLOGY

Canadian guideline for Parkinson disease

(2019) David Grimes et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson’s disease: a pilot study

(2019) Genliang Liu et al.   NEUROLOGICAL SCIENCES

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach

(2018) Angelo Antonini et al.   CURRENT MEDICAL RESEARCH AND OPINION

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) E. Ray Dorsey et al.   LANCET NEUROLOGY

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

(2017) Angelo Antonini et al.   PARKINSONISM & RELATED DISORDERS

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations

(2017) Anthony H. V. Schapira et al.   JAMA Neurology

Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care

(2016) Jacob Taylor et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson’s disease

(2015) Huimin Chen et al.   NEUROLOGICAL SCIENCES

The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa

(2014) R. Cilia et al.   BRAIN

Establishing CUTOFF Values for the Simplified Barthel Index in Elderly Adults in Residential Care Homes

(2014) Simon C. Lam et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Clinical spectrum of levodopa-induced complications

(2014) Camila Catherine Aquino et al.   MOVEMENT DISORDERS

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

(2013) C. Warren Olanow et al.   MOVEMENT DISORDERS

Late-stage Parkinson disease

(2012) Miguel Coelho et al.   Nature Reviews Neurology

Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort design

(2012) David W Brodell et al.   BMJ Open

The self-report Barthel Index: preliminary validation in people with Parkinson’s disease

(2011) D. Morley et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinical problems in the hospitalized Parkinson's disease patient: Systematic review

(2011) Oliver H.H. Gerlach et al.   MOVEMENT DISORDERS

Neurologist care in Parkinson disease: A utilization, outcomes, and survival study

(2011) A. W. Willis et al.   NEUROLOGY

Prevalence of Parkinson’s disease and atypical parkinsonian syndromes in a rural Japanese district

(2010) Y. Osaki et al.   ACTA NEUROLOGICA SCANDINAVICA

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Large differences in levodopa dose requirement in Parkinson’s disease: men use higher doses than women

(2009) D. Nyholm et al.   EUROPEAN JOURNAL OF NEUROLOGY

Changes in Prevalence and Incidence of Parkinson’s Disease in Japan during a Quarter of a Century

(2009) Mika Yamawaki et al.   NEUROEPIDEMIOLOGY

Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight

(2008) J. C. Sharma et al.   EUROPEAN JOURNAL OF NEUROLOGY

Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments

(2008) Elmyra V. Encarnacion et al.   EUROPEAN NEUROLOGY

Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan

(2008) Henry J. Malinowski et al.   JOURNAL OF CLINICAL PHARMACOLOGY